Omeq Medical

Company Overview

Snapshot

Founded in June 2011 by Oded Tsamir and Lior Margalit, Omeq Medical operates with 1–10 employees. The company has secured $4.66 million in total capital across 4 funding rounds from 3 investors. A significant milestone for the company was securing FDA regulatory clearance for its EPiFINDER device in May 2023.

Business overview

Omeq Medical develops a single-use smart needle system designed to enhance the safety and accuracy of epidural injections. Its core technology involves a blunted probe attached to a standard epidural needle, which dynamically monitors tissue forces to precisely detect penetration into the epidural space. Once successful positioning is confirmed visually, a safety mechanism prevents inadvertent spinal puncture. The company operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Assistive Devices, serving healthcare providers in markets such as the United States.

Strategic signal

In May 2023, Omeq Medical secured FDA approval for its EPiFINDER epidural injection device. This regulatory clearance is a critical validation of the device's safety and efficacy, signaling to investors and the medical community that Omeq Medical is poised for commercialization and broader market adoption in the United States, potentially transforming epidural injection procedures.

Company Intelligence Q&A

What is Omeq Medical's primary product?

Omeq Medical's primary product is EPiFINDER, a single-use smart needle system designed for safe and accurate epidural injections.

When was Omeq Medical founded and by whom?

Omeq Medical was founded in June 2011 by Oded Tsamir and Lior Margalit.

What was a key regulatory achievement for Omeq Medical?

In May 2023, Omeq Medical secured FDA regulatory clearance for its EPiFINDER device, enhancing its market readiness.

Which investor participated in Omeq Medical's January 2019 funding round?

In January 2019, Pharos Medical participated in a funding round for Omeq Medical.

Which investor participated in Omeq Medical's July 2013 funding round?

In July 2013, The Trendlines Group participated in a seed funding round for Omeq Medical.